|
 |
|
| AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2009 |
| (Rs. In Lacs) |
| PARTICULARS |
For the
Quarter Ended
|
For the
Quarter Ended
|
For the Year Ended |
30th
June 2010 |
30th
June 2009 |
31st
Mar 2010 |
| 1. |
(a) |
(Net) Sales / Income from operations |
12,528 |
12,126 |
49,695 |
| |
(b) |
Other Operating Income |
710 |
637 |
2,553 |
| 2. |
Expenditure |
| |
(a). |
(Increase) / Decrease in stock in trade |
(426) |
218 |
376 |
| |
(b). |
Consumption of raw materials. |
6,280 |
5,824 |
23,179 |
| |
(c). |
Purchase of Traded Goods |
2,230 |
1,730 |
8,202 |
| |
(d). |
Employees cost |
403 |
321 |
1,362 |
| |
(e). |
Depreciation |
361 |
328 |
1,352 |
| |
(f). |
Other expenditure |
1,808 |
1,443 |
6,859 |
| |
(g). |
Total Expenditure |
10,657 |
9,864 |
41,330 |
| 3. |
Profit from Operating before Other Income |
1,161 |
1,625 |
5,811 |
| 4. |
Other Income |
1 |
2 |
45 |
| 5. |
Profit before Interest & Exceptional Items |
1,162 |
1,627 |
5,856 |
| 6. |
Interest |
274 |
416 |
1,474 |
| 7. |
Profit after Interest but before Exceptional Items |
888 |
1,211 |
4,382 |
| 8. |
Exceptional Items |
- |
- |
- |
| 9. |
Profit from Ordinary Activities before Tax |
888 |
1,211 |
4,382 |
| 10. |
Tax Expenses (Includes) |
291 |
481 |
1,772 |
| |
|
Provision for Taxation |
223 |
413 |
1,502 |
| |
|
Provision for FBT |
68 |
68 |
270 |
| 11. |
Net profit from ordinary Activities after Tax |
598 |
731 |
2,610 |
| 12. |
Extraodinary Item (net of tax expenses ) |
|
|
|
| 13. |
Net Profit for the period |
598 |
731 |
2,610 |
| 14. |
Paid-up Equity Share Capital of Rs.10/- each. |
1,211 |
1,171 |
1,211 |
| 15. |
Reserves & Surplus (excluding revaluation reserves) |
- |
- |
12,898 |
| 16. |
Basic E P S (in Rs.) |
4.94 |
6.24 |
22.08 |
| 17. |
Public Shareholding |
|
|
|
| |
|
Number of Shares |
5833575 |
5329891 |
6051226 |
| |
|
Percentage of Total Shareholding |
48.18 |
45.52 |
49.97 |
| 18. |
Promoters & Promoter Group Shareholding** |
|
|
|
| |
a) |
Pledged/Encumbered |
|
|
|
| |
|
- Number of Shares |
NIL |
NIL |
NIL |
| |
|
-Percentage of shares( as a percentage of the total shareholding of promoter and promoter group) |
NIL |
NIL |
NIL |
| |
|
-Percentage of shares( as a percentage of total sharecapital of the Company) |
NIL |
NIL |
NIL |
| |
b) |
Non-encumbered |
|
|
|
| |
|
- Number of Shares |
6274975 |
6378659 |
6057324 |
| |
|
-Percentage of shares( as a percentage of total shareholding of promoter and promoter group) |
100 |
100 |
100 |
| |
|
-Percentage of shares (as a percentage of total sharecapital of the Company) |
51.82 |
54.48 |
50.03 |
|
|
| Notes : |
| 1. |
The above results, reviewed by the Audit Committee, have been taken on record by the Board of Directors at their meeting held on 30th July, 2009. |
| 2. |
Company is operating as a Single Segment Company, engaged in pharmaceuticals business hence, the disclosure requirement as per AS - 17 'Segment Reporting' is not attracted. |
| 3. |
The figures of the previous periods have been regrouped and rearranged wherever necessary. |
| 4. |
Number of Investors complaints (i) pending at the begaining of quarter :1 (ii) received during the quarter : 2 (Iii) redressed : 3 (iv) pending at the end of the quarter : NIL. |
| For and on behalf of the Board |
| FOR AARTI DRUGS LIMITED |
| Place : Mumbai |
Harshit M. Savla |
| Date : 30th July, 2010 |
( Jt. Managing Director) |
|
|
|
|
|
 |
|
|
|
